{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:21:46Z","timestamp":1787242906086,"version":"build-2736575974"},"reference-count":128,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jcehepatology.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jceh.2021.04.012","type":"journal-article","created":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T04:48:45Z","timestamp":1619844525000},"page":"603-615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hepatogenous Diabetes: A Primer"],"prefix":"10.1016","volume":"11","author":[{"given":"Preetam","family":"Nath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7105-1540","authenticated-orcid":false,"given":"Anil C.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2021.04.012_bib1","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1038\/emm.2015.122","article-title":"Regulation of glucose metabolism from a liver-centric perspective","volume":"48","author":"Han","year":"2016","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jceh.2021.04.012_bib2","article-title":"Systematic review: endocrine abnormalities in patients with liver cirrhosis","volume":"17","author":"Eshraghian","year":"2014","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.jceh.2021.04.012_bib3","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1464-5491.2010.03093.x","article-title":"High prevalence of diabetes mellitus in patients with liver cirrhosis","volume":"27","author":"Wlazlo","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.jceh.2021.04.012_bib4","doi-asserted-by":"crossref","DOI":"10.1089\/dia.2020.2513","article-title":"NAFLD\/NASH and diabetes","volume":"22","author":"Garg","year":"2020","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.jceh.2021.04.012_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2337\/dc19-1113","article-title":"Economic and clinical burden of nonalcoholic steatohepatitis in patients with type 2 diabetes in the US","volume":"43","author":"Younossi","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jceh.2021.04.012_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1572-0241.2005.00307.x","article-title":"Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis","volume":"101","author":"Nishida","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.04.012_bib7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1440-1746.2002.02755.x","article-title":"Clinical implications of hepatogenous diabetes in liver cirrhosis","volume":"17","author":"Holstein","year":"2002","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.04.012_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/hep.510280119","article-title":"Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity","volume":"28","author":"Petrides","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.04.012_bib9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI115340","article-title":"Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis","volume":"88","author":"Petrides","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jceh.2021.04.012_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00075197-200107000-00005","article-title":"New data and new concepts on the role of the liver in glucose homeostasis","volume":"4","author":"Tappy","year":"2001","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jceh.2021.04.012_bib11","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.jhep.2015.08.011","article-title":"Contribution of \u03b2-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: role of severity of liver disease","volume":"63","author":"Grancini","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.04.012_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.diabres.2015.10.002","article-title":"Alterations in carbohydrate metabolism in cirrhotic patients before and after liver transplant","volume":"110","author":"Ramos-Prol","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jceh.2021.04.012_bib13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/BF02233205","article-title":"Cirrhosis and diabetes","volume":"14","author":"Conn","year":"1969","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.jceh.2021.04.012_bib14","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/gast.2002.33650","article-title":"Diabetes increases the risk of acute hepatic failure","volume":"122","author":"El\u2013Serag","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.04.012_bib15","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/liv.13337","article-title":"Hepatogenous diabetes: is it time to separate it from type 2 diabetes?","volume":"37","author":"Orsi","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.04.012_bib16","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2169\/internalmedicine.38.918","article-title":"Significance of oral glucose tolerance test for the diagnosis of diabetes mellitus in patients with liver cirrhosis","volume":"38","author":"Imano","year":"1999","journal-title":"Intern Med"},{"key":"10.1016\/j.jceh.2021.04.012_bib17","first-page":"524","article-title":"Differential diagnosis of diabetes mellitus caused by liver cirrhosis and other type 2","volume":"12","author":"Kim","year":"2006","journal-title":"\ub300\ud55c\uac04\ud559\ud68c\uc9c0 \uc81c"},{"key":"10.1016\/j.jceh.2021.04.012_bib18","first-page":"119","article-title":"Prognostic significance of diabetes in patients with cirrhosis","volume":"20","author":"Bianchi","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.04.012_bib19","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(67)90334-0","article-title":"Glucose tolerance and diabetes in chronic liver disease","volume":"290","author":"Megyesi","year":"1967","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2021.04.012_bib20","series-title":"Glucose Intolerance in Liver Cirrhosis: Role of Hepatic and Non-hepatic Influences","author":"M\u00fcller","year":"1994"},{"key":"10.1016\/j.jceh.2021.04.012_bib21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/dmr.5610050805","article-title":"Glucose metabolism in cirrhosis: a review with some perspectives for the future","volume":"5","author":"Petrides","year":"1989","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/j.jceh.2021.04.012_bib22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/hep.510300306","article-title":"Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation","volume":"30","author":"Merli","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.04.012_bib23","unstructured":"Diabetes [Internet]. [cited 2020 Dec 18]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes."},{"key":"10.1016\/j.jceh.2021.04.012_bib24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1665-2681(19)31030-0","article-title":"The prevalence and clinical characteristics of glucose metabolism disorders in patients with liver cirrhosis. A prospective study","volume":"11","author":"Garc\u00eda-Compe\u00e1n","year":"2012","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2021.04.012_bib25","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.dld.2013.03.009","article-title":"Metabolic syndrome after liver transplantation: short-term prevalence and pre-and post-operative risk factors","volume":"45","author":"Lunati","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2021.04.012_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.numecd.2016.02.015","article-title":"Frequency and characteristics of diabetes in 300 pre-liver transplant patients","volume":"26","author":"Marselli","year":"2016","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.jceh.2021.04.012_bib27","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1007\/s10620-013-2802-y","article-title":"Hepatogenous diabetes in cirrhosis is related to portal pressure and variceal hemorrhage","volume":"58","author":"Jeon","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2021.04.012_bib28","doi-asserted-by":"crossref","first-page":"e3157","DOI":"10.1002\/dmrr.3157","article-title":"Prevalence of diabetes in liver cirrhosis: a systematic review and meta-analysis","volume":"35","author":"Lee","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jceh.2021.04.012_bib29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S2468-1253(16)30205-9","article-title":"Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review","volume":"2","author":"Harris","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.04.012_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev.nutr.19.1.379","article-title":"Regulation of glucose production by the liver","volume":"19","author":"Nordlie","year":"1999","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.jceh.2021.04.012_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.nu.11.070191.002341","article-title":"Hepatic gluconeogenesis\/glycolysis: regulation and structure\/function relationships of substrate cycle enzymes","volume":"11","author":"Pilkis","year":"1991","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.jceh.2021.04.012_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.nutr.17.1.405","article-title":"Regulation of the expression of lipogenic enzyme genes by carbohydrate","volume":"17","author":"Towle","year":"1997","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.jceh.2021.04.012_bib33","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00535-013-0893-z","article-title":"Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension","volume":"49","author":"Ishikawa","year":"2014","journal-title":"J\u00a0Gastroenterol"},{"issue":"suppl 2","key":"10.1016\/j.jceh.2021.04.012_bib34","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.2337\/dc08-s264","article-title":"Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?","volume":"31","author":"Shanik","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jceh.2021.04.012_bib35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0168-8278(01)00232-X","article-title":"Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis\u2013amelioration by liver transplantation","volume":"36","author":"\u0160ebekov\u00e1","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.04.012_bib36","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2174\/138161208784139747","article-title":"Advanced glycation end products and insulin resistance","volume":"14","author":"Unoki","year":"2008","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.jceh.2021.04.012_bib37","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/MEG.0b013e3281532b9a","article-title":"Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses","volume":"19","author":"Anty","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.04.012_bib38","doi-asserted-by":"crossref","first-page":"7075","DOI":"10.3748\/wjg.v12.i44.7075","article-title":"Insulin resistance and hepatitis C","volume":"12","author":"Romero-G\u00f3mez","year":"2006","journal-title":"World J Gastroenterol WJG"},{"key":"10.1016\/j.jceh.2021.04.012_bib39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amjmed.2010.08.012","article-title":"Hyperinsulinemia and the development of nonalcoholic fatty liver disease in nondiabetic adults","volume":"124","author":"Rhee","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jceh.2021.04.012_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/351974","article-title":"Predictors of impaired glucose regulation in patients with non-alcoholic fatty liver disease","volume":"2012","author":"Hatziagelaki","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.jceh.2021.04.012_bib41","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm.2851","article-title":"Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance","volume":"18","author":"Pal","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jceh.2021.04.012_bib42","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cmet.2015.09.023","article-title":"Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism","volume":"22","author":"Meex","year":"2015","journal-title":"Cell Metabol"},{"key":"10.1016\/j.jceh.2021.04.012_bib43","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cmet.2010.09.015","article-title":"A\u00a0liver-derived secretory protein, selenoprotein P, causes insulin resistance","volume":"12","author":"Misu","year":"2010","journal-title":"Cell Metabol"},{"key":"10.1016\/j.jceh.2021.04.012_bib44","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.molmet.2017.07.016","article-title":"Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease","volume":"6","author":"Baumeier","year":"2017","journal-title":"Mol Metab"},{"key":"10.1016\/j.jceh.2021.04.012_bib45","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00125-016-3991-7","article-title":"A\u00a0novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes","volume":"59","author":"Wu","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.jceh.2021.04.012_bib46","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"150","author":"Machado","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.04.012_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmet.2007.05.005","article-title":"Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver","volume":"6","author":"Monetti","year":"2007","journal-title":"Cell Metabol"},{"key":"10.1016\/j.jceh.2021.04.012_bib48","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.04.012_bib49","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.2337\/db15-0242","article-title":"Inactivation of NF-\u03baB p65 (RelA) in liver improves insulin sensitivity and inhibits cAMP\/PKA pathway","volume":"64","author":"Ke","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jceh.2021.04.012_bib50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.20283","article-title":"Free fatty acids promote hepatic lipotoxicity by stimulating TNF-\u03b1 expression via a lysosomal pathway","volume":"40","author":"Feldstein","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.04.012_bib51","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/jhep.2001.28055","article-title":"High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis","volume":"34","author":"Paradis","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.04.012_bib53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0168-8278(88)80512-9","article-title":"Abnormal tissue oxygenation in patients with cirrhosis and liver failure","volume":"7","author":"Moreau","year":"1988","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.04.012_bib54","doi-asserted-by":"crossref","first-page":"G582","DOI":"10.1152\/ajpgi.90368.2008","article-title":"Reduced liver fibrosis in hypoxia-inducible factor-1\u03b1-deficient mice","volume":"296","author":"Moon","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jceh.2021.04.012_bib55","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1478-3231.2004.0961.x","article-title":"Hypoxia potentiates transforming growth factor-\u03b2 expression of hepatocyte during the cirrhotic condition in rat liver","volume":"24","author":"Jeong","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.04.012_bib56","doi-asserted-by":"crossref","first-page":"E710","DOI":"10.1152\/ajpendo.00052.2019","article-title":"Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2\u03b1\/PPAR\u03b1 pathway","volume":"317","author":"Chen","year":"2019","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"10.1016\/j.jceh.2021.04.012_bib57","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1172\/JCI35846","article-title":"Hypoxia-inducible factor-1\u03b1 regulates \u03b2 cell function in mouse and human islets","volume":"120","author":"Cheng","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jceh.2021.04.012_bib58","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/hep.21611","article-title":"Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A","volume":"46","author":"Christen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.04.012_bib59","doi-asserted-by":"crossref","first-page":"37251","DOI":"10.1074\/jbc.M110.142315","article-title":"Chronic ethanol consumption-induced pancreatic \u03b2-cell dysfunction and apoptosis through glucokinase nitration and its down-regulation","volume":"285","author":"Kim","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jceh.2021.04.012_bib60","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.metabol.2009.08.006","article-title":"Effect of iron overload on glucose metabolism in patients with hereditary hemochromatosis","volume":"59","author":"Hatunic","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.jceh.2021.04.012_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-015-0404-1","article-title":"Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study","volume":"15","author":"Lesmana","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jceh.2021.04.012_bib62","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/MPA.0b013e3181f6fce2","article-title":"Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease","volume":"39","author":"van Geenen","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.jceh.2021.04.012_bib63","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.3748\/wjg.v16.i34.4329","article-title":"Associated factors for a hyperechogenic pancreas on endoscopic ultrasound","volume":"16","author":"Choi","year":"2010","journal-title":"World J Gastroenterol WJG"},{"key":"10.1016\/j.jceh.2021.04.012_bib64","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/MPA.0b013e3181a9d5af","article-title":"Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study","volume":"38","author":"Al-Haddad","year":"2009","journal-title":"Pancreas"},{"key":"10.1016\/j.jceh.2021.04.012_bib65","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3389\/fphys.2017.00787","article-title":"Brain ceramide metabolism in the control of energy balance","volume":"8","author":"Cruciani-Guglielmacci","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.jceh.2021.04.012_bib66","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1179721","article-title":"Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5","volume":"328","author":"Vijay-Kumar","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jceh.2021.04.012_bib67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.1188876","article-title":"The microbes made me eat it","volume":"328","author":"Sandoval","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jceh.2021.04.012_bib68","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/gutjnl-2011-301012","article-title":"Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota","volume":"61","author":"Serino","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.04.012_bib69","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2021.04.012_bib70","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jceh.2021.04.012_bib71","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2021.04.012_bib72","first-page":"585","article-title":"Tumor necrosis factor-\u03b1 regulates in\u00a0vivo expression of the rat UCP family differentially","volume":"1436","author":"Masaki","year":"1999","journal-title":"Biochim Biophys Acta BBA-Mol Cell Biol Lipids"},{"key":"10.1016\/j.jceh.2021.04.012_bib73","first-page":"4196","article-title":"Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-\u03b1, in\u00a0vivo","volume":"82","author":"Mohamed-Ali","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jceh.2021.04.012_bib74","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1046\/j.1365-2826.2003.01096.x","article-title":"White adipose tissue: getting nervous","volume":"15","author":"Fliers","year":"2003","journal-title":"J\u00a0Neuroendocrinol"},{"key":"10.1016\/j.jceh.2021.04.012_bib75","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1440-1746.2002.02755.x","article-title":"Clinical implications of hepatogenous diabetes in liver cirrhosis","volume":"17","author":"Holstein","year":"2002","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.04.012_bib76","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2893.2005.00677.x","article-title":"Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis","volume":"13","author":"Papatheodoridis","year":"2006","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jceh.2021.04.012_bib77","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/hep.27228","article-title":"Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C","volume":"60","author":"Elkrief","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.04.012_bib78","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1478-3231.2004.0991.x","article-title":"Clinical characteristics and outcome of patients with cirrhosis and refractory ascites","volume":"24","author":"Moreau","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.04.012_bib79","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/jgh.13240","article-title":"Additive impact of pre-liver transplant metabolic factors on survival post-liver transplant","volume":"31","author":"Adams","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.04.012_bib80","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s10620-014-3469-8","article-title":"Diabetes mellitus, and not obesity, is associated with lower survival following liver transplantation","volume":"60","author":"Wong","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2021.04.012_bib81","first-page":"OC01","article-title":"Cirrhosis of liver and diabetes mellitus: the diabolic duo?","volume":"11","author":"Ramachandran","year":"2017","journal-title":"J\u00a0Clin Diagn Res JCDR"},{"key":"10.1016\/j.jceh.2021.04.012_bib82","article-title":"Diabetes mellitus\u2013related all-cause and cardiovascular mortality in a national cohort of adults","volume":"8","author":"Raghavan","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jceh.2021.04.012_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-60142-y","article-title":"Diabetes and all-cause mortality, a 18-year follow-up study","volume":"10","author":"Salehidoost","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2021.04.012_bib84","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1007\/s10620-016-4261-8","article-title":"Diabetes is associated with clinical decompensation events in patients with cirrhosis","volume":"61","author":"Liu","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2021.04.012_bib85","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5858\/2006-130-27-DHDMOT","article-title":"Diabetic hepatosclerosis: diabetic microangiopathy of the liver","volume":"130","author":"Harrison","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jceh.2021.04.012_bib86","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/PAS.0000000000000419","article-title":"Hepatic arteriolosclerosis: a small vessel complication of diabetes and hypertension","volume":"39","author":"Balakrishnan","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jceh.2021.04.012_bib87","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1478-3231.2007.01562.x","article-title":"Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis","volume":"27","author":"Kalaitzakis","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.04.012_bib88","doi-asserted-by":"crossref","first-page":"378","DOI":"10.7326\/0003-4819-98-3-378","article-title":"Disorders of gastrointestinal motility associated with diabetes mellitus","volume":"98","author":"Feldman","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2021.04.012_bib89","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1111\/j.1572-0241.2002.05791.x","article-title":"Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia","volume":"97","author":"Bauer","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.04.012_bib90","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2036.2005.02590.x","article-title":"Type 2 diabetes and chronic liver disease in the Verona diabetes study","volume":"22","author":"Trombetta","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2021.04.012_bib91","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3748\/wjg.15.280","article-title":"Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management","volume":"15","author":"Garcia-Compean","year":"2009","journal-title":"World J Gastroenterol WJG"},{"key":"10.1016\/j.jceh.2021.04.012_bib92","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/dmrr.1291","article-title":"Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"28","author":"Wang","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jceh.2021.04.012_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027326","article-title":"The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies","volume":"6","author":"Yang","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jceh.2021.04.012_bib94","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc1387","article-title":"Insulin-like growth factors and neoplasia","volume":"4","author":"Pollak","year":"2004","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.jceh.2021.04.012_bib95","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1001\/jama.2008.824","article-title":"Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis","volume":"300","author":"Barone","year":"2008","journal-title":"Jama"},{"key":"10.1016\/j.jceh.2021.04.012_bib96","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4254\/wjh.v3.i5.99","article-title":"Insulin resistance and chronic liver disease","volume":"3","author":"Kawaguchi","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2021.04.012_bib97","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.3748\/wjg.v22.i10.2869","article-title":"Hepatogenous diabetes: is it a neglected condition in chronic liver disease?","volume":"22","author":"Garc\u00eda-Compe\u00e1n","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.04.012_bib98","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF02900711","article-title":"Fructosamine and glycated hemoglobin as indices of glycemic control in patients with liver cirrhosis","volume":"20","author":"Trenti","year":"1990","journal-title":"Res Clin Lab"},{"key":"10.1016\/j.jceh.2021.04.012_bib99","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/lt.23495","article-title":"Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value","volume":"18","author":"Tandon","year":"2012","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2021.04.012_bib100","article-title":"Physical exercise for people with cirrhosis","volume":"12","author":"Aamann","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jceh.2021.04.012_bib101","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.clinre.2017.09.005","article-title":"Physical exercise in cirrhotic patients: towards prehabilitation on waiting list for liver transplantation. A systematic review and meta-analysis","volume":"42","author":"Brustia","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jceh.2021.04.012_bib102","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/lt.22472","article-title":"Exercise capacity and muscle strength in patients with cirrhosis","volume":"18","author":"Jones","year":"2012","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2021.04.012_bib103","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2016.38","article-title":"Changes in hepatic venous pressure gradient induced by physical exercise in cirrhosis: results of a pilot randomized open clinical trial","volume":"7","author":"Mac\u00edas-Rodr\u00edguez","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jceh.2021.04.012_bib104","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jhep.2018.06.017","article-title":"Exercise in cirrhosis: translating evidence and experience to practice","volume":"69","author":"Tandon","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.04.012_bib105","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/ajg.2016.336","article-title":"Frailty as tested by gait speed is an independent risk factor for cirrhosis complications that require hospitalization","volume":"111","author":"Dunn","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.04.012_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-016-0763-7","article-title":"Short physical performance battery and all-cause mortality: systematic review and meta-analysis","volume":"14","author":"Pavasini","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.jceh.2021.04.012_bib107","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/lt.25449","article-title":"The range and reproducibility of the liver frailty index","volume":"25","author":"Wang","year":"2019","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2021.04.012_bib108","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jceh.2021.04.012_bib109","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00002018-199920040-00006","article-title":"Lactic acidosis in metformin-treated patients","volume":"20","author":"Lalau","year":"1999","journal-title":"Drug Saf"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2021.04.012_bib110","first-page":"45","article-title":"Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review","volume":"17","author":"Renda","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jceh.2021.04.012_bib111","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.4254\/wjh.v7.i12.1652","article-title":"Systematic review: preventive and therapeutic applications of metformin in liver disease","volume":"7","author":"Bhat","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2021.04.012_bib112","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/hep.27199","article-title":"Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes","volume":"60","author":"Zhang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.04.012_bib113","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/gutjnl-2011-301708","article-title":"Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in\u00a0vitro studies","volume":"62","author":"Chen","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2021.04.012_bib114","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/00365521.2012.719926","article-title":"Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis","volume":"48","author":"Zhang","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.04.012_bib115","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1478-3231.2010.02223.x","article-title":"Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease","volume":"30","author":"Donadon","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.04.012_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049279","article-title":"Metformin inhibits glutaminase activity and protects against hepatic encephalopathy","volume":"7","author":"Ampuero","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jceh.2021.04.012_bib117","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4103\/ijem.IJEM_512_16","article-title":"Consensus statement on dose modifications of antidiabetic agents in patients with hepatic impairment","volume":"21","author":"Gangopadhyay","year":"2017","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.jceh.2021.04.012_bib118","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2337\/dc06-1539","article-title":"Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease","volume":"30","author":"Tolman","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jceh.2021.04.012_bib119","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1463-1326.2001.00103.x","article-title":"Effect of treatment with acarbose and insulin in patients with non-insulin-dependent diabetes mellitus associated with non-alcoholic liver cirrhosis","volume":"3","author":"Gentile","year":"2001","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.jceh.2021.04.012_bib120","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1542-3565(04)00667-6","article-title":"A\u00a0randomized controlled trial of acarbose in hepatic encephalopathy","volume":"3","author":"Gentile","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.04.012_bib121","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2169\/internalmedicine.40.484","article-title":"Hepatic necrosis with cholestasis induced by long-term voglibose administration","volume":"40","author":"Kawakami","year":"2001","journal-title":"Intern Med"},{"key":"10.1016\/j.jceh.2021.04.012_bib122","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3748\/wjg.v19.i15.2298","article-title":"Dipeptidyl peptidase-4: a key player in chronic liver disease","volume":"19","author":"Itou","year":"2013","journal-title":"World J Gastroenterol WJG"},{"key":"10.1016\/j.jceh.2021.04.012_bib123","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrendo.2011.243","article-title":"SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects","volume":"8","author":"Ferrannini","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jceh.2021.04.012_bib124","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.clinthera.2011.09.011","article-title":"Influence of hepatic impairment on the pharmacokinetics and safety profile of dapagliflozin: an open-label, parallel-group, single-dose study","volume":"33","author":"Kasichayanula","year":"2011","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.jceh.2021.04.012_bib125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/cld.714","article-title":"SGLT2 inhibitors and cirrhosis: a unique perspective on the comanagement of diabetes mellitus and ascites","volume":"11","author":"Saffo","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2021.04.012_bib126","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/hep.31270","article-title":"Sodium-glucose cotransporter 2 inhibitors (SGLT2-I) ameliorate ascites and peripheral edema in patients with cirrhosis and diabetes","volume":"72","author":"Montalvo-Gordon","year":"2020","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2021.04.012_bib127","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.cgh.2020.05.021","article-title":"SGLT2 inhibitors in liver patients","volume":"18","author":"Hsiang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.04.012_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-016-0789-4","article-title":"SGLT2 inhibitors: benefit\/risk balance","volume":"16","author":"Scheen","year":"2016","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.jceh.2021.04.012_bib129","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/bmj.280.6219.976","article-title":"Can insulin-treated diabetics be given beta-adrenergic blocking drugs?","volume":"280","author":"Barnett","year":"1980","journal-title":"Br Med J"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321000992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321000992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:25:23Z","timestamp":1698971123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688321000992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":128,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0973688321000992"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2021.04.012","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatogenous Diabetes: A Primer","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2021.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}